C

CTXR

Citius Pharmaceuticals Inc

0.77

0.05+6.51%
After Hours: 0.7900  +0.0210  +2.73%19:40 05/02 EDT

Financial Statements

Statement:

Key indicator

Income Statement

Balance Sheet

Cash Flow

Reporting Period:

Accumulated Report

FY

YoY:
FY: Financial Year Annual Report
Q: Quarter is quarterly reports. Q1, Q2, Q3 and Q4 are reports for a single quarter. Q6 and Q9 are accumulated quarterly reports, respectively contain 6 months' reports and 9 months' report.
Item
FY 2024
FY 2023
FY 2022
FY 2021
FY 2020
Total Assets

116.65M

103.61M

114.00M

142.43M

43.77M

Total Current Assets

14.22M

34.37M

44.56M

72.81M

13.98M

Total Non Current Assets

102.43M

69.24M

69.44M

69.61M

29.79M

Total Liabilities

42.55M

12.18M

10.57M

9.65M

10.10M

Total Current Liabilities

35.81M

5.78M

4.53M

3.98M

4.10M

Total Non Current Liabilities

6.74M

6.40M

6.04M

5.66M

6.01M

Total Equity

74.10M

91.43M

103.43M

132.78M

33.67M

Total Stockholders Equity

70.08M

90.83M

102.83M

132.18M

33.67M

Minority Interest

4.02M

600.38K

600.38K

600.38K

--

Total Liabilities & Shareholders Equity

116.65M

103.61M

114.00M

142.43M

43.77M

Total Common Shares Outstanding

7.25M

6.35M

5.85M

5.84M

2.22M

Total Preferred Shares Outstanding

--

--

--

--

--